Tag Archives: docetaxel-resistance

miR-34a is an intracellular and exosomal predictive biomarker


Docetaxel-resistance limits successful treatment of castration resistant prostate cancer. Researchers at Trinity College Dublin previously demonstrated that extracellular vesicles (exosomes) may play a role in regulating docetaxel resistance. Here, they investigated intracellular and extracellular (exosomal) miRNAs related to docetaxel resistance. ...

Read More »